SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Chronic Stable Angina Global Clinical Trials Review, H1, 2013 Provides Briefing Pertaining To the Number of Trials for the Key Drugs

[March 12, 2013]

Research and Markets: Chronic Stable Angina Global Clinical Trials Review, H1, 2013 Provides Briefing Pertaining To the Number of Trials for the Key Drugs

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/f5b9sc/chronic_stable) has announced the addition of GlobalData's new report "Chronic Stable Angina Global Clinical Trials Review, H1, 2013" to their offering.

The clinical trial report, Chronic Stable Angina Global Clinical Trials Review, H1, 2013" provides data on the Chronic Stable Angina clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Stable Angina. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining o the number of trials for the key drugs for treating Chronic Stable Angina. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.


Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

- Listings of discontinued trials (suspended, withdrawn and terminated)

Companies Mentioned:

Chong Kun Dang Pharmaceutical Corp.

Gilead Sciences, Inc.

Roxane Laboratories, Inc.

Ranbaxy Laboratories Limited

Pfizer Inc.

Mylan Inc.

The Medicines Company

Les Laboratoires Servier SAS (News - Alert)

Cardiovascular Consultants, Ltd.

Actavis Inc.

CNS, Inc.

Nanjing University

Yamagata University Hospital

Kumamoto University

Shaheed Beheshti Medical University

King's College London

For more information visit http://www.researchandmarkets.com/research/f5b9sc/chronic_stable

Source (News - Alert): GlobalData


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2013 Technology Marketing Corporation. All rights reserved.